State Street Corp Karyopharm Therapeutics Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, State Street Corp holds 409,510 shares of KPTI stock, worth $339,893. This represents 0.0% of its overall portfolio holdings.

Number of Shares
409,510
Previous 453,810 9.76%
Holding current value
$339,893
Previous $394,000 13.96%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$0.7 - $1.06 $31,009 - $46,958
-44,300 Reduced 9.76%
409,510 $339,000
Q2 2024

Aug 14, 2024
SELL
$0.87 - $1.58 $1.59 Million - $2.89 Million
-1,831,978 Reduced 80.15%
453,810 $394,000
Q1 2024

May 15, 2024
BUY
$0.72 - $1.66 $167,050 - $385,144
232,015 Added 11.3%
2,285,788 $3.45 Million
Q4 2023

Feb 14, 2024
BUY
$0.68 - $1.31 $7,322 - $14,106
10,768 Added 0.53%
2,053,773 $1.77 Million
Q3 2023

Nov 14, 2023
SELL
$1.14 - $1.81 $193,072 - $306,545
-169,362 Reduced 7.66%
2,043,005 $2.74 Million
Q2 2023

Aug 14, 2023
SELL
$1.79 - $4.59 $14.3 Million - $36.6 Million
-7,963,622 Reduced 78.26%
2,212,367 $3.96 Million
Q1 2023

May 15, 2023
BUY
$2.84 - $3.92 $5.36 Million - $7.4 Million
1,888,953 Added 22.79%
10,175,989 $39.6 Million
Q4 2022

Feb 14, 2023
SELL
$2.48 - $5.93 $1.79 Million - $4.29 Million
-723,303 Reduced 8.03%
8,287,036 $28.2 Million
Q3 2022

Nov 15, 2022
SELL
$4.08 - $5.82 $5.51 Million - $7.87 Million
-1,351,670 Reduced 13.04%
9,010,339 $49.2 Million
Q2 2022

Aug 15, 2022
SELL
$4.15 - $8.37 $2.51 Million - $5.06 Million
-604,692 Reduced 5.51%
10,362,009 $46.7 Million
Q1 2022

May 16, 2022
BUY
$5.91 - $14.38 $32.2 Million - $78.4 Million
5,453,021 Added 98.9%
10,966,701 $80.8 Million
Q4 2021

Feb 14, 2022
SELL
$5.21 - $8.61 $13.1 Million - $21.6 Million
-2,506,319 Reduced 31.25%
5,513,680 $35.5 Million
Q3 2021

Nov 15, 2021
BUY
$4.45 - $10.63 $9.81 Million - $23.4 Million
2,203,450 Added 37.88%
8,019,999 $46.7 Million
Q2 2021

Aug 16, 2021
BUY
$8.11 - $11.11 $3.93 Million - $5.38 Million
484,269 Added 9.08%
5,816,549 $60 Million
Q1 2021

May 17, 2021
SELL
$9.85 - $17.69 $74,653 - $134,072
-7,579 Reduced 0.14%
5,332,280 $56.1 Million
Q4 2020

Feb 16, 2021
BUY
$14.15 - $17.19 $7.8 Million - $9.47 Million
550,885 Added 11.5%
5,339,859 $82.7 Million
Q3 2020

Nov 10, 2020
BUY
$14.14 - $19.71 $2.69 Million - $3.75 Million
190,027 Added 4.13%
4,788,974 $69.9 Million
Q2 2020

Aug 14, 2020
BUY
$16.6 - $25.25 $22.4 Million - $34.1 Million
1,351,460 Added 41.62%
4,598,947 $87.1 Million
Q1 2020

May 11, 2020
BUY
$14.38 - $27.72 $46.7 Million - $90 Million
3,247,487 New
3,247,487 $62.4 Million

Others Institutions Holding KPTI

# of Institutions
98
Shares Held
57.6M
Call Options Held
258K
Put Options Held
81.2K
View Full List

About Karyopharm Therapeutics Inc.

KPTI Quotes by TradingView
  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $66.2M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email